PL368573A1 - Pharmaceutical compound influencing growth and mineralization processes in the axial and the appendicular skeleton as well as bone diseases of mature years among humans and animals as well as application of the pharmaceutical compound in the process of growth and mineralization of axial and appendicular skeleton and bone diseases of mature years among humans and animals - Google Patents

Pharmaceutical compound influencing growth and mineralization processes in the axial and the appendicular skeleton as well as bone diseases of mature years among humans and animals as well as application of the pharmaceutical compound in the process of growth and mineralization of axial and appendicular skeleton and bone diseases of mature years among humans and animals

Info

Publication number
PL368573A1
PL368573A1 PL04368573A PL36857304A PL368573A1 PL 368573 A1 PL368573 A1 PL 368573A1 PL 04368573 A PL04368573 A PL 04368573A PL 36857304 A PL36857304 A PL 36857304A PL 368573 A1 PL368573 A1 PL 368573A1
Authority
PL
Poland
Prior art keywords
humans
animals
axial
well
pharmaceutical compound
Prior art date
Application number
PL04368573A
Other languages
Polish (pl)
Inventor
Tadeusz Studziński
Stefan Pierzynowski
Ewa Śliwa
Original Assignee
Sgp & Sons Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34972626&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL368573(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sgp & Sons Ab filed Critical Sgp & Sons Ab
Priority to PL04368573A priority Critical patent/PL368573A1/en
Priority to PCT/PL2005/000037 priority patent/WO2005123059A1/en
Publication of PL368573A1 publication Critical patent/PL368573A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL04368573A 2004-06-17 2004-06-17 Pharmaceutical compound influencing growth and mineralization processes in the axial and the appendicular skeleton as well as bone diseases of mature years among humans and animals as well as application of the pharmaceutical compound in the process of growth and mineralization of axial and appendicular skeleton and bone diseases of mature years among humans and animals PL368573A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL04368573A PL368573A1 (en) 2004-06-17 2004-06-17 Pharmaceutical compound influencing growth and mineralization processes in the axial and the appendicular skeleton as well as bone diseases of mature years among humans and animals as well as application of the pharmaceutical compound in the process of growth and mineralization of axial and appendicular skeleton and bone diseases of mature years among humans and animals
PCT/PL2005/000037 WO2005123059A1 (en) 2004-06-17 2005-06-16 Alpha-ketoglutatic acid or derivatives thereof for the treatment of osteoporosis and related diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL04368573A PL368573A1 (en) 2004-06-17 2004-06-17 Pharmaceutical compound influencing growth and mineralization processes in the axial and the appendicular skeleton as well as bone diseases of mature years among humans and animals as well as application of the pharmaceutical compound in the process of growth and mineralization of axial and appendicular skeleton and bone diseases of mature years among humans and animals

Publications (1)

Publication Number Publication Date
PL368573A1 true PL368573A1 (en) 2005-12-27

Family

ID=34972626

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04368573A PL368573A1 (en) 2004-06-17 2004-06-17 Pharmaceutical compound influencing growth and mineralization processes in the axial and the appendicular skeleton as well as bone diseases of mature years among humans and animals as well as application of the pharmaceutical compound in the process of growth and mineralization of axial and appendicular skeleton and bone diseases of mature years among humans and animals

Country Status (2)

Country Link
PL (1) PL368573A1 (en)
WO (1) WO2005123059A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101309678B (en) * 2005-11-15 2011-04-20 安特瑞斯公司 Drugs for applications related to cartilage damage
US9801905B2 (en) 2014-03-13 2017-10-31 Hossam Abdel Salam El Sayed Mohamed Use of organic sulphur, antioxidants, and amino acids in conjunction with exercise and electromagnetic stimulation to treat osteoporosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190570B (en) * 1986-05-20 1988-02-16 Rotta Research Lab METAFLUOROPHOSPHATE ION SALTS WITH AMINO ACIDS HAVING REGULAR ACTIVITY IN THE METABOLISM OF THE ARTICULAR OSTEO FABRIC AND PROCEDURE FOR THEIR PREPARATION
CN1060336C (en) * 1995-12-05 2001-01-10 孔彦平 Medicine for prevention and treatment of calcium deficiency and its prepn
US20020147237A1 (en) * 2001-01-31 2002-10-10 Lars Wiklund Preservation of bodily protein
SE0201713D0 (en) * 2001-11-23 2002-06-06 Gramineer Internat Ab New methods and use III

Also Published As

Publication number Publication date
WO2005123059A1 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
EP1816996A4 (en) Methods and therapeutic compositions comprising plant extracts for the treatment of cancer
PL1976886T3 (en) Means and methods for the treatment of tumorous diseases
SI1679058T1 (en) Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases
IL182643A0 (en) Novel composition and methods for the treatment of immune related diseases
EP1575480A4 (en) Compositions and methods for the treatment of immune related diseases
EP1578367A4 (en) Compositions and methods for the treatment of immune related diseases
EP1572116A4 (en) Compositions and methods for the treatment of immune related diseases
EP1576137A4 (en) Compositions and methods for the treatment of immune related diseases
PL1611091T3 (en) Substituted phenylalkanoic acid derivatives and their use for respiratory disease treatment
IL182010A0 (en) Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
GB0811801D0 (en) Compositions and methods relating to treatment of cancer and infectious diseases
EP1560593A4 (en) Novel composition and methods for the treatment of immune related diseases
AU2003268531A8 (en) Materials and methods for treatment of allergic diseases
SI1919290T1 (en) Methods and products for treatment of diseases
EP1781107A4 (en) Herbal pharmaceutical compositions for prophylaxis and/or treatment of cardiovascular diseases and the method of preparing the same
ZA200609584B (en) Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof
PL371081A1 (en) Pharmaceutical compound with the effect on the growth and the mineralization of osseous-skeleton system and on mature years bone and cartilage diseases among humans and animals, and method for its application
ZA200806095B (en) Means and methods for the treatment of tumorous diseases
IL184849A0 (en) Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
GB0404209D0 (en) Materials and methods for treatment of allergic disease
EP1765331A4 (en) Methods and compositions for the treatment of pulmonary diseases
IL179039A0 (en) Method of using and compositions comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases
PL368573A1 (en) Pharmaceutical compound influencing growth and mineralization processes in the axial and the appendicular skeleton as well as bone diseases of mature years among humans and animals as well as application of the pharmaceutical compound in the process of growth and mineralization of axial and appendicular skeleton and bone diseases of mature years among humans and animals
EP1740221A4 (en) Methods and compositions for the treatment of polycystic diseases

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)